These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


293 related items for PubMed ID: 16000156

  • 1. Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors.
    Pakkanen JS, Nousiainen H, Yli-Kauhaluoma J, Kylänlahti I, Möykkynen T, Korpi ER, Peng JH, Lukas RJ, Ahtee L, Tuominen RK.
    J Neurochem; 2005 Sep; 94(5):1329-41. PubMed ID: 16000156
    [Abstract] [Full Text] [Related]

  • 2. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R, Salminen O, Tuominen RK.
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic nicotine treatment on localization of neuronal nicotinic acetylcholine receptors at cellular level.
    Pakkanen JS, Stenfors J, Jokitalo E, Tuominen RK.
    Synapse; 2006 Jun 01; 59(7):383-93. PubMed ID: 16485261
    [Abstract] [Full Text] [Related]

  • 4. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M, Hellström-Lindahl E.
    Neurochem Int; 2009 Jun 01; 54(3-4):237-44. PubMed ID: 19111588
    [Abstract] [Full Text] [Related]

  • 5. Nicotine-induced upregulation of human neuronal nicotinic alpha7-receptors is potentiated by modulation of cAMP and PKC in SH-EP1-halpha7 cells.
    Nuutinen S, Ekokoski E, Lahdensuo E, Tuominen RK.
    Eur J Pharmacol; 2006 Aug 21; 544(1-3):21-30. PubMed ID: 16846598
    [Abstract] [Full Text] [Related]

  • 6. Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.
    Zhao L, Kuo YP, George AA, Peng JH, Purandare MS, Schroeder KM, Lukas RJ, Wu J.
    J Pharmacol Exp Ther; 2003 Jun 21; 305(3):1132-41. PubMed ID: 12626641
    [Abstract] [Full Text] [Related]

  • 7. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
    Ambrose V, Miller JH, Dickson SJ, Hampton S, Truman P, Lea RA, Fowles J.
    Nicotine Tob Res; 2007 Aug 21; 9(8):793-9. PubMed ID: 17654292
    [Abstract] [Full Text] [Related]

  • 8. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH, Fryer JD, Hurst RS, Schroeder KM, George AA, Morrissy S, Groppi VE, Leonard SS, Lukas RJ.
    J Pharmacol Exp Ther; 2005 Apr 21; 313(1):24-35. PubMed ID: 15590768
    [Abstract] [Full Text] [Related]

  • 9. Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells: contribution of voltage-operated Ca2+ channels and Ca2+ stores.
    Dajas-Bailador FA, Mogg AJ, Wonnacott S.
    J Neurochem; 2002 May 21; 81(3):606-14. PubMed ID: 12065669
    [Abstract] [Full Text] [Related]

  • 10. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J, Anderson DJ, Grønlien JH, Ji J, Bunnelle WH, Håkerud M, Thorin-Hagene K, Ween H, Helfrich R, Hu M, Gubbins E, Gopalakrishnan S, Puttfarcken PS, Briggs CA, Li J, Meyer MD, Dyhring T, Ahring PK, Nielsen EØ, Peters D, Timmermann DB, Gopalakrishnan M.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):863-74. PubMed ID: 20504915
    [Abstract] [Full Text] [Related]

  • 11. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonist.
    Feuerbach D, Nozulak J, Lingenhoehl K, McAllister K, Hoyer D.
    Neurosci Lett; 2007 Apr 06; 416(1):61-5. PubMed ID: 17314009
    [Abstract] [Full Text] [Related]

  • 12. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs.
    Xiao Y, Smith RD, Caruso FS, Kellar KJ.
    J Pharmacol Exp Ther; 2001 Oct 06; 299(1):366-71. PubMed ID: 11561100
    [Abstract] [Full Text] [Related]

  • 13. The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation.
    Garcia-Ratés S, Camarasa J, Sánchez-García AI, Gandía L, Escubedo E, Pubill D.
    Toxicol Appl Pharmacol; 2010 May 01; 244(3):344-53. PubMed ID: 20132834
    [Abstract] [Full Text] [Related]

  • 14. Modulation of alpha7 nicotinic receptor-mediated calcium influx by nicotinic agonists.
    Quik M, Philie J, Choremis J.
    Mol Pharmacol; 1997 Mar 01; 51(3):499-506. PubMed ID: 9058606
    [Abstract] [Full Text] [Related]

  • 15. Differential coupling of alpha7 and non-alpha7 nicotinic acetylcholine receptors to calcium-induced calcium release and voltage-operated calcium channels in PC12 cells.
    Dickinson JA, Hanrott KE, Mok MH, Kew JN, Wonnacott S.
    J Neurochem; 2007 Feb 01; 100(4):1089-96. PubMed ID: 17181555
    [Abstract] [Full Text] [Related]

  • 16. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
    Gopalakrishnan M, Molinari EJ, Sullivan JP.
    Mol Pharmacol; 1997 Sep 01; 52(3):524-34. PubMed ID: 9281615
    [Abstract] [Full Text] [Related]

  • 17. Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta.
    Hu J, DeChon J, Yan KC, Liu Q, Hu G, Wu J.
    Neurosci Lett; 2006 Jul 31; 403(1-2):57-62. PubMed ID: 16730119
    [Abstract] [Full Text] [Related]

  • 18. Local and global calcium signals associated with the opening of neuronal alpha7 nicotinic acetylcholine receptors.
    Gilbert D, Lecchi M, Arnaudeau S, Bertrand D, Demaurex N.
    Cell Calcium; 2009 Feb 31; 45(2):198-207. PubMed ID: 19038445
    [Abstract] [Full Text] [Related]

  • 19. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec 31; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

  • 20. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
    Liu Q, Yu KW, Chang YC, Lukas RJ, Wu J.
    Acta Pharmacol Sin; 2008 Mar 31; 29(3):305-19. PubMed ID: 18298895
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.